The Strength Within: Evaluating Lecturers' Resilience Levels | Chapter 7 | New Advances in Business, Management and Economics Vol. 5

Resilience is the ability to demonstrate both strength and flexibility during the change process while exhibiting minimal dysfunctional behavior. Staff’s commitment to organizational change and overall performance is positively influenced by resilience. Facing the challenges of new norms in the era of the COVID-19 pandemic requires to have a high level of resilience. The staff of many organizations must deal with a variety of challenges, changes, and uncertainties. In particular, lecturers in educational leadership and management training institutes must possess strong resilience to navigate these challenges effectively. This study aimed to explore the resilience level of lecturers in terms of their resilience level, profile, and differences in relation to their demographic background. A quantitative-based cross-sectional research design was employed for this study. A questionnaire was distributed to the lecturers from a training institute in Malaysia as the samples for this study using stratified random sampling. The results from a total of 200 respondents were analyzed. Data were analyzed quantitatively using Statistical Package for Social Sciences (SPSS) Version 18. There were seven domains of resilience explored in this study. Based on the finding, it was found that the overall resilience level of staff from this training institute was very high. Specifically, very high for four domains and high for the other three domains. It was also found that there was a significant difference in resilience level in relation to their retirement age. This study revealed that the lecturers from the training institute have a high level of resilience. This could stem from the existing working culture within the training institution itself, whereby it has become a norm for the lecturers to be agile, dynamic, and flexible in the ever-changing education system. The results showed that the lecturers’ resilience level was on par with what the institution required. However, the resilience level needs to be steadily improved for future endeavors due to unforeseen uncertainties. Therefore, this study may function as leverage for the management of these institutions to take necessary actions to further strengthen the resilience level among the lecturers, especially for the domains with a lower level.

 

Author (s) Details

 

Rahayu Ahamad Bahtiar
Institute Aminuddin Baki, Malaysia.

 

Siti Fairuz Murshid
Institute Aminuddin Baki, Malaysia.

 

Husna Yahya
Institute Aminuddin Baki, Malaysia.

 

Netty Yushani Yusof
Institute Aminuddin Baki, Malaysia.

 

Please see the book here:- https://doi.org/10.9734/bpi/nabme/v5/5026

Investigating Neurological Symptoms of Infectious Diseases Like COVID-19 Leads to a Deeper Understanding of Neurodegenerative Disorders | Chapter 10 | Current Overview on Disease and Health Research Vol. 2

 

Patients with COVID-19 frequently experience neurological symptoms in addition to typical respiratory symptoms. According to studies, SARS-CoV-2 infection increased alpha-synuclein aggregation, created Lewy-body-like pathology, accelerated the senescence of dopaminergic neurons, and aggravated Parkinson's disease symptoms in patients (PD). Additionally, SARS-CoV-2 infection can cause neuroinflammation, accelerate neurodegeneration in protracted COVID, and increase a person's susceptibility to Parkinson's disease (PD) or parkinsonism. These results imply that the present COVID-19 pandemic may be followed by a post-COVID-19 parkinsonism. This paper reviewed the neurological symptoms and associated findings of COVID-19, related infectious diseases (influenza, AIDS, and prion disease), and neurodegenerative diseases (Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, and multiple sclerosis), and discussed potential mechanisms underlying the neurological symptoms and the relationship between them. the neurodegenerative illnesses and infectious diseases, as well as the consequences for treatment and prevention of neurodegenerative disorders. Over time, alpha-synuclein "prions" and infections with a variety of microorganisms (such as SARS-CoV-2, influenza A viruses, gut bacteria, etc.) may combine to cause Parkinson's disease (PD). Thus, a methodical strategy that concentrates on these infections as well as the pathogen-caused neuroinflammation and neurodegeneration may offer treatments for neurodegenerative diseases. To treat, manage, or prevent these conditions, antiviral/antimicrobial medications, vaccines, immunotherapies, and novel treatments (such as stem cell therapy) must collaborate. Better SARS-CoV-2 vaccines, new antiviral/antimicrobial medications, efficient immunotherapies (alpha-synuclein antibodies, vaccinations for PD or parkinsonism, etc.), as well as novel therapeutics, are projected to be created and made accessible in the future as medical research and technology evolve.

Author(s) Details:

Jing Zhang,
Department of Neurology, School of Medicine, Washington University in St. Louis, St. Louis, MO 63110, US.

Please see the link here: https://stm.bookpi.org/CODHR-V2/article/view/7750